Business Wire

CA-CHARGEPOINT

19.6.2024 09:01:31 CEST | Business Wire | Press release

Share
ChargePoint Reinforces its be.ENERGISED EV Charger Management Solution

ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), today announced a suite of updates and additions to its be.ENERGISED platform, a leading European software solution for the management of charging networks and e-mobility services at scale.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619736580/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

be.ENERGISED now manages over 900 models of charging stations from more than 100 manufacturers. New features, offerings and enhancements include:

  • The first payment terminal to meet the new OCPI v2.2.1 Direct Payment Module industry standards and comply with the recently instated AFIR (Alternative Fuel Infrastructure Regulation).
  • eMobility Service Providers (eMSPs) can use the solutions’ roaming network to give their drivers selected access to more than 750,000 stations across the whole of Europe. Charge Point Operators (CPOs) can easily make their stations available to the public and all drivers on the major eMSPs via be.ENERGISED COMMUNITY roaming agreements in just a few clicks of a mouse.
  • In addition, the CP6000 - ChargePoint’s most flexible and serviceable global AC EV charging solution - is available from this week on the be.ENERGISED platform to select customers. The CP6000 is designed for scalability, flexibility, and reliability, offering reliable AC charging for 1 or 3 phase power at an adaptable output of 3.7 to 22kw per port.

ChargePoint’s be.ENERGISED platform boasts consolidated services for CPOs and eMSPs, including VAT handling, automated invoicing, streamlining financial operations for multinational charging providers. With over 85,000 charging ports and 30 million charging sessions per month, be.ENERGISED’s scale and experience are unparalleled in the industry. The software offers an end-to-end solution capable of addressing every aspect of the charging process, providing unmatched flexibility and modularity to cater to all use cases.

The EV charging landscape is rapidly evolving, with CPOs and eMSPs becoming far more sophisticated, often relying on many makes of chargers and hundreds of software integrations with partners. As their expertise deepens, so do their needs, transforming from initial solutions into intricate networks which require robust protection and management. This shift signifies a move from the early days of greenfield projects to the current “brownfield” environment, where existing charger investments must be futureproofed alongside the implementation of new infrastructure. Though new chargers are constantly being brought online, ensuring a reliable network requires legacy hardware running just as well as the newest installations. All of this underscores the need for a well-rounded, adaptable software solution such as be.ENERGISED.

“A new set of market demands necessitates even the most advanced charger management platforms to deliver innovative features for the future,” said Andreas Blin, Director for Service Provision at ChargePoint. “A leader in the market for more than a decade, be.ENERGISED meets the challenges charging businesses face, ensuring that both new and existing infrastructure can excel in an ever more dynamic environment.”

Since acquiring be.ENERGISED three years ago, ChargePoint has continued to foster and develop the product to ensure market leadership while delivering bespoke solutions for international customers. be.ENERGISED is now the most flexible and comprehensive solution on the market, and one built for the future without forgetting about the past.

To learn more about ChargePoint’s be.ENERGISED platform, please click here or visit the ChargePoint stand B6.111Hall B6 at the Power2Drive charging infrastructure exposition in Munich held June 19-21st.

About ChargePoint Holdings, Inc.

ChargePoint is creating a new fuelling network to move people and goods on electricity. Since 2007, ChargePoint has been committed to making it easy for businesses and drivers to go electric with one of the largest EV charging networks and a comprehensive portfolio of charging solutions. The ChargePoint cloud subscription platform and software-defined charging hardware are designed to include options for every charging scenario from home and multifamily to workplace, parking, hospitality, retail, and transport fleets of all types. Today, one ChargePoint account provides access to hundreds-of-thousands of places to charge in North America and Europe. For more information, visit the ChargePoint pressroom, the ChargePoint Investor Relations site, or contact the ChargePoint North American or European press office or Investor Relations.

CHPT-IR

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240619736580/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye